Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib.
| Image |  |
|---|---|
| Description | scientific article published on 30 July 2013 |
| Author/s |
author: Rocio I. Macias Javier Vaquero Luis Bujanda Jose J Marin Jesus M Banales Elisa Herraez Aguilar |
| Publication date | July 30, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |